PARP Inhibitors in Prostate Cancer – Recent Updates and Implications for Clinical Practice
This CME-accredited activity, PARP Inhibitors in Prostate Cancer – Recent Updates and Implications for Clinical Practice, is designed to provide expert interpretation of new and emerging data on the treatment of prostate cancer with PARP inhibitors (PARPi) as a single agen
Category
- GU Cancer
Format
- Conference / meeting
- Hybrid
Credits
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Nursing Contact Hours
Event date October 29, 2023
2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes- Webcast
This accredited continuing education activity “Webcast 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes”, is recorded from the live webinar held on 10/07/2022- 10/08/22.
Category
- Breast Cancer
- GI Cancers
- GU Cancer
- Hematologic Malignancies
- Lung Cancer
- Precision Oncology
Format
- Video
- Webinar recorded
Credits
- 6.50 ABIM MOC II
- 6.50 AMA PRA Category 1 Credit™
- 6.50 Nursing Contact Hours